Selected Grants
Duke University Program in Environmental Health
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029Single Cell and Spatial Analysis of Lethal Breast Cancers
ResearchPrincipal Investigator · Awarded by Department of Defense · 2024 - 2028The paradox of obesity, tumor progression, and checkpoint inhibition in TNBC
ResearchMentor · Awarded by Susan G Komen for the Cure · 2023 - 2026A Window-of-Opportunity Trial Using Neoadjuvant Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
ResearchCollaborator · Awarded by Marc Lustgarten Pancreatic Cancer Foundation · 2023 - 2026Visualizing tumor heterogeneity in an immune intact and autochthonous mouse model of breast cancer
ResearchCo-Mentor · Awarded by National Cancer Institute · 2021 - 2026Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory
ResearchPrincipal Investigator · Awarded by Department of Defense · 2021 - 2025Beyond PD1: An immunotherapeutic strategy to stimulate and enable both T-cell and B-cell responses in immunosuppressive and non-mutated metastatic breast cancer
ResearchCo Investigator · Awarded by Department of Defense · 2020 - 2025Determinants of geographic disparities in mortality and multimorbidity in the U.S.
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2025Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color
ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2025Viral Oncology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1980 - 2025Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
ResearchCollaborator · Awarded by National Cancer Institute · 2019 - 2024Hebei Bio-High Technology Visiting Researcher Training
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Hebei Bio-High Technology Development CO. LTD · 2020 - 2022Defining the Rules of Breast Cancer Cell Traffic Through Bone
ResearchCollaborator · Awarded by National Institutes of Health · 2017 - 2022Detection and Elimination of Oncogenic Signaling Networks in Pre-malignant and Malignant Cells with Magnetic Resonance Imaging
ResearchPrincipal Investigator · Awarded by Department of Defense · 2012 - 2022Developing a HER3 Vaccine to Prevent Resistance to Endocrine Therapy
ResearchPrincipal Investigator · Awarded by Department of Defense · 2012 - 2022Translational Research in Surgical Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2022A Molecular Framework for Understanding DCIS
ResearchPrincipal Investigator · Awarded by Department of Defense · 2014 - 2022Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behavior
ResearchCollaborator · Awarded by National Institutes of Health · 2017 - 2021Mechanisms of Action and Resistance to PD-1 Immunotherapies in Breast Cancer
ResearchCollaborator · Awarded by Merck · 2017 - 2020Immunotherapeutic Targeting of a Therapy Resistant Oncogenic HER2 Isoform
ResearchCo-Mentor · Awarded by Susan G. Komen Breast Cancer Foundation · 2017 - 2020Investigating Adaptive Immune Recognition of Dormant Disseminated Tumor Cells
ResearchPrincipal Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2017 - 2019Inhibition of Wnt/B-Catenin Signaling in Colorectal Cancer Therapy
ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2019Duke University Program in Environmental Health
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Environmental Health Sciences · 2013 - 20193D Biology Signatures defined by Nanostring Max System
EquipmentMajor User · Awarded by North Carolina Biotechnology Center · 2018 - 2019Duke-Komen Fundamentals Training for Patient Advocates - AAADV
ConferencePrincipal Investigator · Awarded by Susan G. Komen Breast Cancer Foundation · 2018 - 2018A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2018AAADV Fundamentals
ConferencePrincipal Investigator · Awarded by Susan G. Komen Breast Cancer Foundation · 2017 - 2017Advancing Immunology in Dogs with Naturally-occurring Invasive Bladder Cancer, a Relevant Model to Improve Immunotherapy Across Molecular Cancer Subtypes in Humans
ResearchPrincipal Investigator · Awarded by Purdue University · 2016 - 2017A Simple System for Early Detection of Breast Cancer
ResearchCo Investigator · Awarded by Arizona State University · 2014 - 2017AAADV Scholars
ConferencePrincipal Investigator · Awarded by Millennium Pharmaceuticals, Inc. · 2016 - 2017AAADV Scholars
ConferencePrincipal Investigator · Awarded by Genentech, Inc. · 2016 - 2016AAADV Scholars
ConferencePrincipal Investigator · Awarded by Pfizer, Inc. · 2016 - 2016AAADV Workshop
ConferencePrincipal Investigator · Awarded by Susan G Komen for the Cure · 2015 - 2016Cancer Biology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Cancer Institute · 1993 - 2016Integrating Population and Basic Science in Cancer Research
ResearchAdvisor · Awarded by National Institutes of Health · 2009 - 2015Clinical Oncology Research Career Development Program
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 20152015 Accelerating Anticancer Agent Development and Validation Workshop
ConferencePrincipal Investigator · Awarded by Susan G Komen for the Cure · 2015 - 2015A Cancer Rainbow Mouse for the Simultaneous Assessment of Multiple Oncogenes
ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2015Administrative Supplement for Recruitment of New Faculty
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2009 - 2011Immunotherapy with High Frequency, CEA Specific
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2000 - 2011SPORE in Breast Cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2010Cancer Center Core Grant Supplement - Accelerating Anticancer Agent Development Workshop
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2009Cancer Center Core Grant Supplement - Accelerating Anticancer Agent Dev Workshop
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2005 - 2009Targeting hCG-beta for Breast Cancer Immunotherapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2009Developing Biomarker-Based Prognostics in Breast Cancer
ResearchSponsor · Awarded by National Institutes of Health · 2004 - 2009Vaccination with Regulatory T Cell Depletion
ResearchConsultant · Awarded by National Institutes of Health · 2006 - 2008Novel Biomarkers for Aromatase Inhibitor Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2008Markers of short term breast cancer risk in FNA
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2008Phase II trial of Cetuximab & Carboplatin in Basal-like Breast Cancer
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2008Biomarker Studies for Novel Anti-Cancer Agents
ResearchConsultant · Awarded by National Institutes of Health · 2003 - 2008Dendritic Cell Based Immunotherapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2007Immunotherapy using peptide MHC tetramer isolated Tcells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2007Dendritic Cell Mobilization and Active Immunotherapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2007Immunologic Correlates of Effective Immunizations for Cancer Vaccines
ResearchConsultant · Awarded by National Institutes of Health · 2001 - 2006Planning a Duke Academic Public Private Partnership Program (AP4) Center
Institutional SupportPrincipal Investigator · Awarded by National Cancer Institute · 2004 - 2006Phase II Trial of Estradiol Therapy for Advanced Breast Cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2005Mentored Oriented Research Career Development Award
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2000 - 2005Cancer Center Core Grant - CURE Supplment
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2004Immunotherapy of Prostate Cancer with Tumor Vaccines
ResearchSponsor · Awarded by National Institutes of Health · 1999 - 2004RNA Transfected Dendritic Cells for Cancer Immunotherapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004Dexasome Based Immunotherapy of Lung Cancer
ResearchConsultant · Awarded by National Institutes of Health · 2001 - 2004Immunotherapy with TRICOM Modified Dendritic Cells
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2003Cytomation MoFlo High Performance Flow Cytometer
EquipmentPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2003Dendritic Cell Immunotherapy For Breast Cancer
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2000Cancer Immunotherapy With Rna Pulsed Dendritic Cells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 1999Immunotherapy With Peptide Pulsed Dendritic Cells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999Immunotherapy with peptide pulsed dendritic cell
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999Viral Control And Immune Reconstitution In Hiv Infection
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1999Viral Control & Immune Reconstitution In Hiv Infection
Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1999Immunotherapy Of Breast Cancer With Gene Modified Tumor
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1999Immunotherapy of Breast Cancer with Gene Modified Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1999Immunotherapy Of Breast Cance5 With Gene Modified Tumor
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1999DUMC AIDS Malignancy Program
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1999Dumc Aids Malignancy Program
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1999Spore In Breast Cancer
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1998Spore In Breast Cancer
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1998Surrogate Markers Of Tumor Specific Immunity
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1994 - 1998Preclinical Development Of Rna Decoys
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1994 - 1998Adoptive Immunotherapy For Aids Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 1996Cellular Immunity Against Post-Transplant Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1992 - 1994External Relationships
- AlphaVax
- Biologic Response Laboratories
- HuaDong Pharmaceutical Company
- ImmunityBio
- Oncosec
- Replicate
- Sonokine Bioscience
- State of North Carolina Environmental Management Commission
- TRIO Biopharma
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.